Related Experiment Video
Updated: Jul 18, 2026
In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids
Zhian Xiu1,2, Qian Yang3, Fusheng Xie1,2
1Department of Medical Laboratory, Clinical Medical College, Affiliated Hospital of Jiujiang University, Jiujiang, Jiangxi, China.
Abstract:
Digestive system tumors are the leading cause of cancer-related deaths worldwide. Despite ongoing research, our understanding of their mechanisms and treatment remain inadequate. One promising tool for clinical applications is the use of gastrointestinal tract tumor organoids, which serve as an important in vitro model. Tumor organoids exhibit a genotype similar to the patient's tumor and effectively mimic various biological processes, including tissue renewal, stem cell, and ecological niche functions, and tissue response to drugs, mutations, or injury. As such, they are valuable for drug screening, developing novel drugs, assessing patient outcomes, and supporting immunotherapy. In addition, innovative materials and techniques can be used to optimize tumor organoid culture systems. Several applications of digestive system tumor organoids have been described and have shown promising results in related aspects. In this review, we discuss the current progress, limitations, and prospects of this model for digestive system tumors.
Insights
Digestive system tumor organoids offer a promising in vitro model for understanding cancer mechanisms and improving treatments. These models mimic patient tumors, aiding in drug screening and personalized medicine approaches.
Area of Science:
- Oncology
- Biotechnology
- Gastroenterology
Background:
- Digestive system tumors are a major global health concern, with inadequate understanding of their mechanisms and treatment.
- Current research faces challenges in developing effective therapeutic strategies for these cancers.
Purpose of the Study:
- To review the progress, limitations, and future prospects of digestive system tumor organoids as an in vitro model.
- To highlight the utility of organoids in drug screening, development, and personalized medicine for gastrointestinal cancers.
Main Methods:
- Review of current literature on digestive system tumor organoids.
- Analysis of organoid capabilities in mimicking tumor biology and drug responses.
- Discussion of innovative culture techniques and materials.
Main Results:
- Digestive system tumor organoids accurately replicate patient tumor genotypes and biological functions.
- Organoids demonstrate efficacy in drug screening, predicting patient outcomes, and supporting immunotherapy.
- Optimization of organoid culture systems using novel materials and techniques is ongoing.
Conclusions:
- Digestive system tumor organoids represent a valuable tool for advancing cancer research and clinical applications.
- Further development and application of organoid models hold significant promise for improving the treatment of digestive system cancers.
- Organoids are crucial for personalized medicine, drug discovery, and understanding cancer biology.
More Related Videos
07:31Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
Published on: May 26, 2023
05:57Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
Published on: May 30, 2025
